Merck (MRK) Income from Continuing Operations (2016 - 2025)
Merck (MRK) has disclosed Income from Continuing Operations for 17 consecutive years, with 2963000000.0 as the latest value for Q4 2025.
- On a quarterly basis, Income from Continuing Operations fell 20.86% to 2963000000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 18263000000.0, a 6.59% increase, with the full-year FY2025 number at 18263000000.0, up 6.6% from a year prior.
- Income from Continuing Operations was 2963000000.0 for Q4 2025 at Merck, down from 5787000000.0 in the prior quarter.
- In the past five years, Income from Continuing Operations ranged from a high of 5787000000.0 in Q3 2025 to a low of 5975000000.0 in Q2 2023.
- A 5-year average of 3134700000.0 and a median of 3784000000.0 in 2021 define the central range for Income from Continuing Operations.
- Peak YoY movement for Income from Continuing Operations: plummeted 251.3% in 2023, then soared 415.15% in 2024.
- Merck's Income from Continuing Operations stood at 3824000000.0 in 2021, then decreased by 21.08% to 3018000000.0 in 2022, then plummeted by 139.36% to 1188000000.0 in 2023, then skyrocketed by 415.15% to 3744000000.0 in 2024, then decreased by 20.86% to 2963000000.0 in 2025.
- Per Business Quant, the three most recent readings for MRK's Income from Continuing Operations are 2963000000.0 (Q4 2025), 5787000000.0 (Q3 2025), and 4428000000.0 (Q2 2025).